Enterococcal septicemia in patients with hematological malignancies

M. Venditti, A. Tarasi, U. Visco Comandini, G. Gentile, C. Girmenia, A. Micozzi, P. Martino

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Thirty-six cases of enterococcal septicemia in patients with hematological malignancies were reviewed retrospectively and categorized according to their clinical significance using strict previously described definitions. Overall, most of the infected patients were males (77 %), had acute leukemia (64 %), had recently received cytotoxic drug therapy (86 %), were granulocytopenic at the onset of septicemia (77 %), and acquired the infection during hospitalization (77 %). The source of septicemia was unknown in 18 (50 %) patients, intestinal in 15 (42 %) and intravascular in three (8 %). Mortality was 19 % among 21 inpatients who had clinically significant septicemia and 30 % among patients with septicemia of uncertain clinical significance. The fatal outcome could be definitively attributed to enterococcal septicemia in only one of the nine inpatients who died. Clinically significant septicemia appeared somewhat more frequently to be polymicrobial (p=0.06), whereas septicemia of unknown significance presented more frequently as breakthrough septicemia (p=0.013). Unless associated with intravascular infection, enterococcal septicemia in patients with hematological malignancies seems to represent a marker of cytotoxic drug damage of the intestinal mucosa rather than a truly invasive infection.

Original languageEnglish
Pages (from-to)241-247
Number of pages7
JournalEuropean Journal of Clinical Microbiology and Infectious Diseases
Volume12
Issue number4
DOIs
Publication statusPublished - Apr 1993

Fingerprint

Hematologic Neoplasms
Sepsis
Inpatients
Infection
Fatal Outcome
Intestinal Mucosa
Leukemia
Hospitalization
Drug Therapy
Mortality

ASJC Scopus subject areas

  • Microbiology (medical)
  • Immunology

Cite this

Enterococcal septicemia in patients with hematological malignancies. / Venditti, M.; Tarasi, A.; Comandini, U. Visco; Gentile, G.; Girmenia, C.; Micozzi, A.; Martino, P.

In: European Journal of Clinical Microbiology and Infectious Diseases, Vol. 12, No. 4, 04.1993, p. 241-247.

Research output: Contribution to journalArticle

Venditti, M. ; Tarasi, A. ; Comandini, U. Visco ; Gentile, G. ; Girmenia, C. ; Micozzi, A. ; Martino, P. / Enterococcal septicemia in patients with hematological malignancies. In: European Journal of Clinical Microbiology and Infectious Diseases. 1993 ; Vol. 12, No. 4. pp. 241-247.
@article{5df97b67ff07489091b67bcc377c714f,
title = "Enterococcal septicemia in patients with hematological malignancies",
abstract = "Thirty-six cases of enterococcal septicemia in patients with hematological malignancies were reviewed retrospectively and categorized according to their clinical significance using strict previously described definitions. Overall, most of the infected patients were males (77 {\%}), had acute leukemia (64 {\%}), had recently received cytotoxic drug therapy (86 {\%}), were granulocytopenic at the onset of septicemia (77 {\%}), and acquired the infection during hospitalization (77 {\%}). The source of septicemia was unknown in 18 (50 {\%}) patients, intestinal in 15 (42 {\%}) and intravascular in three (8 {\%}). Mortality was 19 {\%} among 21 inpatients who had clinically significant septicemia and 30 {\%} among patients with septicemia of uncertain clinical significance. The fatal outcome could be definitively attributed to enterococcal septicemia in only one of the nine inpatients who died. Clinically significant septicemia appeared somewhat more frequently to be polymicrobial (p=0.06), whereas septicemia of unknown significance presented more frequently as breakthrough septicemia (p=0.013). Unless associated with intravascular infection, enterococcal septicemia in patients with hematological malignancies seems to represent a marker of cytotoxic drug damage of the intestinal mucosa rather than a truly invasive infection.",
author = "M. Venditti and A. Tarasi and Comandini, {U. Visco} and G. Gentile and C. Girmenia and A. Micozzi and P. Martino",
year = "1993",
month = "4",
doi = "10.1007/BF01967253",
language = "English",
volume = "12",
pages = "241--247",
journal = "European Journal of Clinical Microbiology and Infectious Diseases",
issn = "0934-9723",
publisher = "Vieweg",
number = "4",

}

TY - JOUR

T1 - Enterococcal septicemia in patients with hematological malignancies

AU - Venditti, M.

AU - Tarasi, A.

AU - Comandini, U. Visco

AU - Gentile, G.

AU - Girmenia, C.

AU - Micozzi, A.

AU - Martino, P.

PY - 1993/4

Y1 - 1993/4

N2 - Thirty-six cases of enterococcal septicemia in patients with hematological malignancies were reviewed retrospectively and categorized according to their clinical significance using strict previously described definitions. Overall, most of the infected patients were males (77 %), had acute leukemia (64 %), had recently received cytotoxic drug therapy (86 %), were granulocytopenic at the onset of septicemia (77 %), and acquired the infection during hospitalization (77 %). The source of septicemia was unknown in 18 (50 %) patients, intestinal in 15 (42 %) and intravascular in three (8 %). Mortality was 19 % among 21 inpatients who had clinically significant septicemia and 30 % among patients with septicemia of uncertain clinical significance. The fatal outcome could be definitively attributed to enterococcal septicemia in only one of the nine inpatients who died. Clinically significant septicemia appeared somewhat more frequently to be polymicrobial (p=0.06), whereas septicemia of unknown significance presented more frequently as breakthrough septicemia (p=0.013). Unless associated with intravascular infection, enterococcal septicemia in patients with hematological malignancies seems to represent a marker of cytotoxic drug damage of the intestinal mucosa rather than a truly invasive infection.

AB - Thirty-six cases of enterococcal septicemia in patients with hematological malignancies were reviewed retrospectively and categorized according to their clinical significance using strict previously described definitions. Overall, most of the infected patients were males (77 %), had acute leukemia (64 %), had recently received cytotoxic drug therapy (86 %), were granulocytopenic at the onset of septicemia (77 %), and acquired the infection during hospitalization (77 %). The source of septicemia was unknown in 18 (50 %) patients, intestinal in 15 (42 %) and intravascular in three (8 %). Mortality was 19 % among 21 inpatients who had clinically significant septicemia and 30 % among patients with septicemia of uncertain clinical significance. The fatal outcome could be definitively attributed to enterococcal septicemia in only one of the nine inpatients who died. Clinically significant septicemia appeared somewhat more frequently to be polymicrobial (p=0.06), whereas septicemia of unknown significance presented more frequently as breakthrough septicemia (p=0.013). Unless associated with intravascular infection, enterococcal septicemia in patients with hematological malignancies seems to represent a marker of cytotoxic drug damage of the intestinal mucosa rather than a truly invasive infection.

UR - http://www.scopus.com/inward/record.url?scp=0027289057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027289057&partnerID=8YFLogxK

U2 - 10.1007/BF01967253

DO - 10.1007/BF01967253

M3 - Article

C2 - 8513811

AN - SCOPUS:0027289057

VL - 12

SP - 241

EP - 247

JO - European Journal of Clinical Microbiology and Infectious Diseases

JF - European Journal of Clinical Microbiology and Infectious Diseases

SN - 0934-9723

IS - 4

ER -